The US FDA’s marketing authorisation of two low-nicotine cigarettes as modified risk tobacco products – including a menthol cigarette – has not gone down well with public health associations or all harm reduction experts…
Author: Antonia Di Lorenzo
-
-
Italian Senators consider amendments to modify HnB excise duties from 2022
Written by Antonia Di Lorenzo | 17th December 2021 | News analysis
Italian senators from different political parties have tabled a number of amendments to the Budget Bill 2022 aiming to modify the excise tax rates on heated tobacco products…
-
What caused a scrap in the Philippines government over tobacco alternatives?
Written by Antonia Di Lorenzo | 24th November 2021 | Blog , News analysis
Conflict between public health and political-economic interests seems to be the main reason behind an internal dispute between the Philippine delegation to COP9 and officials at the country’s Department of Health…
-
UK Tobacco Control Plan 'must tackle misinformation' about alternatives
Written by Antonia Di Lorenzo | 18th November 2021 | News analysis
UK MPs have called on the government to ensure that the forthcoming Tobacco Control Plan will be taken as an opportunity to tackle misinformation around tobacco alternatives and to encourage switching…
-
Concern grows over influencers' social media promotion of tobacco products
Written by Antonia Di Lorenzo | 10th November 2021 | Blog , News analysis
The misleading advertising of tobacco alternatives on social media has become a critical concern of public health groups and some governments around the world…
-
JTI to focus energy on the 'encouraging' performance of Ploom X in Japan
Written by Antonia Di Lorenzo | 2nd November 2021 | News analysis
Japan Tobacco International (JTI) has posted positive figures for the first nine months of the year, with a good performance from its reduced-risk products in its domestic market…
-
Altria sees revenue decline in Q3, but its oral portfolio is on the rise
Written by Antonia Di Lorenzo | 29th October 2021 | News analysis
Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US…
-
Sales up, profit down as Swedish Match pins high hopes on a smoke-free future
Written by Antonia Di Lorenzo | 28th October 2021 | News analysis
Swedish Match has reported 9% growth in global sales in the first nine months of 2021, driven by its smoke-free portfolio in the US and Scandinavia, but profit and market share have not lived up to forecast…
-
US FDA authorises sale of oral tobacco products taken off the market in 2019
Written by Antonia Di Lorenzo | 21st October 2021 | News analysis
The US Food and Drug Administration (FDA) has issued marketing authorisation for four mint-flavoured oral tobacco products that were withdrawn from the US market in 2019…
-
'Utopian' - but is a global consensus on smoke-free alternatives a realistic goal?
Written by Antonia Di Lorenzo | 14th October 2021 | Blog , News analysis
A global consensus between industry, scientists and regulators around the role of tobacco alternatives in smoking cessation could be reached in the long term, but experts believe achieving more cooperation is a major challenge…
-
WHO FCTC members urged to change attitude towards tobacco alternatives
Written by Antonia Di Lorenzo | 27th September 2021 | News analysis
Industry representatives have called for a change of heart within the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) to improve the governance and evolution of the global industry…
-
Why have WHO FCTC COP9 novel tobacco discussions been postponed to 2023?
Written by Antonia Di Lorenzo | 21st September 2021 | News analysis
The World Health Organization (WHO) has decided to postpone a discussion on novel tobacco products to a face-to-face event in 2023 – a decision experts are linking to a lack of consensus on what approach to take…
-
European cancer report 'should include reference to reduced-harm products'
Written by Antonia Di Lorenzo | 14th September 2021 | News analysis
Three Italian members of the European Parliament (MEPs) are hoping to introduce the concept of harm reduction into a strategy report by the Special Committee on Beating Cancer (BECA), but the idea has not yet been officially endorsed…
-
Nations miss the deadline to implement EU's directive on single-use plastics
Written by Antonia Di Lorenzo | 6th September 2021 | News analysis
Few countries hit the deadline for implementing the EU Single-Use Plastics Directive (SUP) to reduce the environmental impact of certain plastics – including those in heated tobacco filters – TobaccoIntelligence has found…
-
US nicotine pouch sales have grown 300 times in five years: so what’s next?
Written by Antonia Di Lorenzo | 2nd September 2021 | Blog , News analysis
Sales of nicotine pouches in the US have risen 300 times higher over the five years since they entered the US market in 2016, according to figures released by the US Centers for Disease Control and Prevention (CDC)…
-
Young adults smoked more while overall quitting rate doubled in UK lockdown
Written by Antonia Di Lorenzo | 26th August 2021 | News analysis
A study by Cancer Research UK has found that the success rate of attempts to quit smoking in England almost doubled during the first Covid-19 lockdown, while smoking by young adults increased by almost 25%…
-
PMI launches Iqos Iluma in Japan, with new induction-heating technology
Written by Antonia Di Lorenzo | 17th August 2021 | News analysis
Philip Morris International (PMI) has launched Iqos Iluma in Japan today as part of the company’s plan to achieve a smoke-free future…
-
Will the UK government end up blocking PMI-Vectura deal in the public interest?
Written by Antonia Di Lorenzo | 5th August 2021 | Blog , News analysis
The proposal of Philip Morris International (PMI) to acquire inhaled drug delivery company Ventura for $1.2bn has alerted the UK government, which can block the deal if it sees any major public interest reason to do so…
-
JT sees positive numbers amid 'momentum' of its HnB portfolio
Written by Antonia Di Lorenzo | 30th July 2021 | News analysis
JTI posted positive numbers in the first half of the year, with good performance from its reduced-risk products and improvement in its full-year guidance after the launch of Ploom X…
-
Altria announces delay in US Iqos rollout, posts revenue boost for oral tobacco
Written by Antonia Di Lorenzo | 29th July 2021 | News analysis
Altria has presented positive numbers for the first half of the year, while also announcing a delay in further expansion of Iqos consumables in the US until a patent infringement case is resolved…
-
BAT reports slight slip in global revenue while modern oral growth accelerates
Written by Antonia Di Lorenzo | 28th July 2021 | News analysis
British American Tobacco (BAT) has posted a 0.8% global decrease in revenue for the first half of the year, while the performance of its new category portfolio rose by 40.4%…
-
PMI raises its sights for 2021 as Europe leads the rush towards heated tobacco
Written by Antonia Di Lorenzo | 20th July 2021 | News analysis
Philip Morris International (PMI)’s net revenues were up by 10% in the first half of 2021, with smoke-free products accounting for 28.5% of the total…
-
Pouches drive accelerating sales and revenue for confident Swedish Match
Written by Antonia Di Lorenzo | 20th July 2021 | News analysis
The latest figures from Swedish Match show continued momentum in smoke-free tobacco alternatives, with nicotine pouches “the driving force”…
-
PMI acquisition of gums manufacturer 'shows company strategy on alternatives'
Written by Antonia Di Lorenzo | 12th July 2021 | News analysis
PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe…